Misplaced Pages

Oncotherm

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Medical devices used for cancer treatment
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (February 2022) (Learn how and when to remove this message)
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Oncotherm" – news · newspapers · books · scholar · JSTOR (February 2022) (Learn how and when to remove this message)
This article may contain excessive or inappropriate references to self-published sources. Please help improve it by removing references to unreliable sources where they are used inappropriately. (February 2022) (Learn how and when to remove this message)
(Learn how and when to remove this message)

Oncotherm medical devices are produced by Oncotherm Ltd. and used for cancer treatment.

Methodology

The company's methodology is based on the view of its founder that the heat-dose sensitive characterization of tissue is at the core of the oncothermia treatment. The tumor tissue has lower impedance than the surrounding tissues, so most of the energy is transmitted and absorbed by the cancerous lesion. This selection of the tumor tissues (self-focusing) renders external focusing unnecessary.

Company

Oncotherm Ltd. was founded in 1988 by Prof. Dr. András Szász in Hungary. In 2002, it received investment from a German company and was reorganized as a German-Hungarian company consisting of Oncotherm Hungary Ltd and Oncotherm GmbH.

Medical devices

Their main products are the Oncotherm EHY-2000 and the Oncotherm EHY-2030, hyperthermia devices using the thermoelectric effects of electrical fields.

More than 450 devices have been placed into operation, mostly in Germany and South Korea, and performed over 400,000 treatments. The devices are not approved by the U.S. Food and Drug Administration.

References

  1. Szasz A (2007). "Hyperthermia, a modality in the wings". J Cancer Res Ther. 3 (1): 56–66. doi:10.4103/0973-1482.31976. PMID 17998724.
  2. "Oncothermia method | Oncotherm". oncotherm.com. Retrieved 2020-02-25.
  3. aiadmin. "Prof. András Szász". Retrieved 2020-02-29.
  4. "OncoTherm Kft céginformáció, cégkivonat, cégmásolat". i.creditonline.hu. Retrieved 2020-02-29.
  5. "Contact Us | Oncotherm". oncotherm.com. Retrieved 2020-02-29.
  6. "EHY-2000plus | Oncotherm". oncotherm.com. Retrieved 2020-02-29.
  7. "EHY-2030 | Oncotherm".
  8. Oncotherm Official site


Stub icon

This oncology article is a stub. You can help Misplaced Pages by expanding it.

Categories: